By Tom Zanki ( April 10, 2015, 8:31 PM EDT) -- California-based Viking Therapeutics Inc. set terms Friday on a downsized initial public offering that seeks to raise $22.5 million, down from a previous estimate of $60 million, to fund its pipeline anchored by a drug designed to ease rehabilitation after hip-fracture surgery....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.